netFormulary NHS
Ipswich and East Suffolk CCG
North East Essex CCG
East Suffolk and North East Essex NHS Foundation Trust
 Search
 Formulary Chapter 4: Central nervous system - Full Section
Notes:

Joint guidance

NSFT formulary

Please click here for the NSFT formulary

Please note while the Ipswich and East Suffolk Joint formulary mirrors what is noted in the NSFT formulary, Netformulary contains information on other indications where antipsychotics may be used e.g levomepromazine in palliative care

North East Essex CCG

Please click here for the EPUTmental health formulary for use within North East Essex CCG. Note guidance above re: other indications.

Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
04.01 Hypnotics and anxiolytics (0,0)
04.01.01 Hypnotics (1,2)
Benzodiazepines (3,3)
Zaleplon, Zolpidem and Zopiclone (2,1)
Chloral and derivatives (1,1)
Sodium oxybate (0,1)
04.01.02 Anxiolytics (0,0)
Benzodiazepines (1,2)
Buspirone (0,1)
Meprobamate (0,1)
04.01.03 Barbiturates (0,4)
04.02 Drugs used in psychoses and related disorders (0,0)
04.02.01 Antipsychotic Drugs (0,1)
First-Generation Antipsychotic Drugs (7,1)
Second-Generation Antipsychotic Drugs (6,5)
04.02.02 Antipsychotic depot injections (9,1)
04.02.03 Drugs used for mania and hypomania (0,1)
Valproic acid (1,0)
Lithium (2,0)
04.03 Antidepressant drugs (0,0)
04.03.01 Tricyclic and related antidepressant drugs (0,0)
Tricyclic antidepressants (4,6)
Related antidepressants (1,1)
04.03.02 Monoamine-oxidase inhibitors (1,2)
Reverible MAOIs (1,0)
04.03.03 Selective serotonin re-uptake inhibitors (5,2)
04.03.04 Other antidepressant drugs (5,1)
04.04 CNS stimulants and other drugs used for attention deficit hyperactivity disorder (6,0)
Cocaine (0,0)
04.05 Drugs used in the treatment of obesity (0,0)
04.05.01 Anti-obesity drugs acting on the gastro-intestinal tract (1,2)
04.05.02 Centrally acting appetite suppressants (0,2)
04.06 Drugs used in nausea and vertigo (0,1)
Antihistamines (3,1)
Phenothiazines and related drugs (4,2)
Domperidone and metoclopramide (2,0)
5HT3 antagonists (1,4)
Neurokinin receptor antagonist (2,0)
Cannabinoid (0,1)
Hyoscine (1,0)
Other drugs for Ménière's disease (1,0)
04.07 Analgesics (1,0)
04.07.01 Non-opioid analgesics and compound analgesic preparations (0,0)
Non-opioid analgesics (6,8)
04.07.02 Opioid analgesics (0,26)
Weak opioids (5,1)
Strong opioids (6,1)
Breakthrough pain (7,0)
Injectable (7,0)
Other (0,0)
04.07.03 Neuropathic pain (7,1)
Trigeminal neuralgia (0,0)
04.07.04 Antimigraine drugs (0,0)
04.07.04.01 Treatment of the acute migraine attack (0,0)
Analgesics (0,4)
5HT1 agonists (2,5)
Ergot alkaloids (0,2)
Anti-emetics (0,0)
Other drugs for migrane (0,1)
04.07.04.02 Prophylaxis of migraine (6,4)
04.08 Antiepileptics (0,0)
04.08.01 Control of epilepsy (1,0)
Partial seizures with or without secondary generalisation (0,0)
Generalised seizures (0,0)
Carbamazepine and Oxcarbazepine (1,2)
Ethosuximide (1,0)
Gabapentin and pregabalin (1,0)
Lacosamide (1,0)
Lamotrigine (1,0)
Levetiracetam (2,0)
Perampanel (0,0)
Phenobarbital and other barbiturates (4,0)
Phenytoin (1,0)
Retigaine (0,0)
Rufinamide (0,1)
Tiagabine (1,0)
Topiramate (1,0)
Valproate (2,0)
Vigabatrin (1,0)
Zonisamide (1,0)
Benzodiazepines (2,0)
Other Drugs (2,1)
04.08.02 Drugs used in status epilepticus (6,2)
04.08.03 Febrile convulsions (0,0)
04.09 Drugs used in parkinsonism and related disorders (0,0)
04.09.01 Dopaminergic drugs used in Parkinsons disease (1,1)
Dopamine receptor agonists (7,1)
Levodopa (3,1)
Monoamine-oxidase-B inhibitors (2,0)
Catachol-O-methyltransferase inhibitors (3,0)
Amantadine (1,0)
Mild to moderate dementia in Parkinsons disease (1,0)
04.09.02 Antimuscarinic drugs used in parkinsonism (4,1)
04.09.03 Drugs used in essential tremor, chorea, tics, and related disorders (3,1)
Torsion dystonias and other involuntary movements (3,2)
04.09.04 Restless leg syndrome (0,0)
04.10 Drugs used in substance dependence (0,0)
04.10.01 Alcohol dependence (2,2)
04.10.02 Nicotine dependence (3,1)
04.10.03 Opioid dependence (0,0)
Opioid substitution therapy (3,1)
Adjunctive therapy and symptomatic treatment (0,1)
Opioid-receptor antagonists (1,0)
04.11 Drugs for dementia (4,0)
netFormulary